ARTICLE | Clinical News
FluMist Quadrivalent regulatory update
July 18, 2016 7:00 AM UTC
FDA said the benefits of FluMist Quadrivalent from AstraZeneca to prevent seasonal influenza continue to outweigh the risks. The announcement follows the recommendation last month by the U.S. CDC’s Ad...